Stem cell shot could slow Parkinson's – first human trial underway
NCT ID NCT07166757
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 22 times
Summary
This study tests a single injection of special stem cells (XS411) into the brain of people with early-onset Parkinson's disease. The goal is to see if it is safe and can help control symptoms. About 90 participants will take part, first in a small safety phase and then in a larger phase where some get the real treatment and some get a sham procedure. All participants will also take immune-suppressing drugs to prevent rejection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huashan Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200040, China
Conditions
Explore the condition pages connected to this study.